This inventor holds 6 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignee: Alcor Scientific Inc.. Active years: 2014-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014-2026
Title: Francesco Frappa: Innovator in Medical Analysis Technology
Introduction
Francesco Frappa is a notable inventor based in Udine, Italy. He has made significant contributions to the field of medical analysis technology, particularly in the determination of red blood cell properties. With a total of five patents to his name, Frappa's work is at the forefront of innovation in in vitro medical analyses.
Latest Patents
Frappa's latest patents include an apparatus, method, and system for the determination of the aggregation rate of red blood cells. This invention focuses on a method and system that utilize optical systems to assess the aggregation rate of red blood cells and other related parameters such as viscosity, deformability, elasticity, and density. The technology employs induced forces generated by ultrasound waves to disrupt and redistribute red blood cells, enhancing the accuracy of medical analyses.
Career Highlights
Francesco Frappa is currently associated with Alcor Scientific Inc., where he continues to develop innovative solutions in medical technology. His expertise and dedication to research have positioned him as a key figure in his field.
Collaborations
Frappa collaborates with Peter J Sacchetti, working together to advance their research and innovations in medical analysis.
Conclusion
Francesco Frappa's contributions to medical technology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in the understanding and analysis of red blood cells.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
